In our study, disruption of EZH2 by chidamide was demonstrated to inhibit proliferation, induce apoptosis and improve sensitivity to adriamycin through disruption of Smo/Gli-1 pathway in AML cells. The gene discussed is SMO; the disease is acute myeloid leukemia.